Working on the present, thinking about the future
Biotechnology
Hematology
Oncology
Neurology

Miasoma - Bortezomib

 

Indications

• Treatment of patients with multiple myeloma.

• Treatment of patients with mantle cell lymphoma who have received at least

   1 prior therapy.

 

 

Dosage forms

3,5 mg

Prescription information
t Back to product list
Bioprofarma Laboratories
Terrada 1270 (C1416ARD), Buenos Aires, Argentina
(5411) 4016-6200
info@bioprofarma.com